Novozymes A/S (NVZMY) News Today → Guard Against the Coming Financial Upheaval (From Porter & Company) (Ad) Free NVZMY Stock Alerts $63.36 +0.65 (+1.04%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartDividendEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartDividendEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 30, 2024 | finance.yahoo.comNovonesis AS's Dividend AnalysisApril 11, 2024 | marketbeat.comNovozymes A/S Plans Dividend of $0.19 (OTCMKTS:NVZMY)Novozymes A/S (OTCMKTS:NVZMY) declared a dividend on Thursday, April 11th. Shareholders of record on Thursday, May 2nd will be given a dividend of 0.1853 per share by the biotechnology company on Monday, May 20th. The ex-dividend date is Wednesday, May 1st.April 11, 2024 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Short Interest UpdateNovozymes A/S (OTCMKTS:NVZMY - Get Free Report) was the recipient of a large drop in short interest in the month of March. As of March 31st, there was short interest totalling 1,600 shares, a drop of 55.6% from the March 15th total of 3,600 shares. Based on an average daily volume of 19,600 shares, the short-interest ratio is currently 0.1 days.March 20, 2024 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Reaches New 1-Year High at $61.86Novozymes A/S (OTCMKTS:NVZMY) Hits New 12-Month High at $61.86March 12, 2024 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Sees Large Drop in Short InterestNovozymes A/S (OTCMKTS:NVZMY - Get Free Report) was the recipient of a large decrease in short interest in February. As of February 29th, there was short interest totalling 1,300 shares, a decrease of 79.7% from the February 14th total of 6,400 shares. Based on an average daily trading volume, of 97,000 shares, the days-to-cover ratio is presently 0.0 days.February 6, 2024 | msn.comDuPont lifts dividend by ~6% to $0.38/share; initiates $1B stock buyback planFebruary 6, 2024 | seekingalpha.comDuPont’s stock jumps on dividend hike, stock buybackFebruary 2, 2024 | finanznachrichten.deNovozymes A/S: Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completedFebruary 2, 2024 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Announces Earnings ResultsNovozymes A/S (OTCMKTS:NVZMY - Get Free Report) posted its quarterly earnings data on Thursday. The biotechnology company reported $0.36 EPS for the quarter, missing analysts' consensus estimates of $0.47 by ($0.11). Novozymes A/S had a net margin of 17.98% and a return on equity of 22.64%. The company had revenue of $664.46 million for the quarter.February 2, 2024 | finance.yahoo.comSettlement of the combination of Novozymes and Chr. Hansen Holding successfully completedJanuary 31, 2024 | markets.businessinsider.comNovozymes A-S (B) is about to announce its earnings — here's what to expectJanuary 29, 2024 | finance.yahoo.comThe combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partnerJanuary 29, 2024 | finance.yahoo.comMajor shareholder announcementJanuary 12, 2024 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Sees Large Growth in Short InterestNovozymes A/S (OTCMKTS:NVZMY - Get Free Report) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 2,100 shares, a growth of 320.0% from the December 15th total of 500 shares. Based on an average trading volume of 21,600 shares, the days-to-cover ratio is currently 0.1 days.December 13, 2023 | finanznachrichten.deNovozymes A/S: Novozymes and Chr. Hansen announce name of future combined company; NovonesisDecember 13, 2023 | finance.yahoo.comNovozymes and Chr. Hansen announce name of future combined company; NovonesisOctober 19, 2023 | msn.comNovozymes A/S goes ex-dividend tomorrowAugust 9, 2023 | finanznachrichten.deNovozymes A/S: Novozymes delivers results within expectations in the first half of 2023 and narrows the full year outlookMay 4, 2023 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Given Consensus Recommendation of "Hold" by BrokeragesNovozymes A/S (OTCMKTS:NVZMY - Get Rating) has been assigned an average recommendation of "Hold" from the eight brokerages that are covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, five have given a hold recommendation and one hApril 26, 2023 | finanznachrichten.deNovozymes A/S: Novozymes delivers stronger than expected Q1 resultsApril 25, 2023 | msn.comNovozymes's Earnings: A PreviewApril 14, 2023 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Short Interest Up 1,533.3% in MarchNovozymes A/S (OTCMKTS:NVZMY - Get Rating) was the target of a large growth in short interest in March. As of March 31st, there was short interest totalling 4,900 shares, a growth of 1,533.3% from the March 15th total of 300 shares. Based on an average trading volume of 31,300 shares, the days-to-cover ratio is presently 0.2 days.April 9, 2023 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Given Consensus Recommendation of "Hold" by AnalystsShares of Novozymes A/S (OTCMKTS:NVZMY - Get Rating) have earned a consensus recommendation of "Hold" from the ten research firms that are presently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold ratinMarch 30, 2023 | finanznachrichten.deNovozymes A/S: Novozymes' and Chr. Hansen's shareholders approve combination to create a leading global biosolutions partnerMarch 30, 2023 | finance.yahoo.comCombination between Novozymes and Chr. Hansen approved by Novozymes’ shareholdersMarch 28, 2023 | marketwatch.comNovozymes, Chr. Hansen Merger Cleared by US Antitrust RegulatorsMarch 16, 2023 | finance.yahoo.comHow is Novozymes OneHealth leading the probiotic market segment in FIC2023?March 15, 2023 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Receives Consensus Recommendation of "Hold" from AnalystsShares of Novozymes A/S (OTCMKTS:NVZMY - Get Rating) have been given an average rating of "Hold" by the ten brokerages that are covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and one has given a buy rMarch 1, 2023 | bizjournals.comNovozymes swells land holdings in Franklin CountyFebruary 25, 2023 | morningstar.comNo Major Surprises in Novozymes’ Q4 2022 ResultsFebruary 20, 2023 | investing.comNovozymes A/S PT Lowered to DKK425 at BerenbergJanuary 26, 2023 | seekingalpha.comNovozymes A/S (NVZMF) Q4 2022 Earnings Call TranscriptJanuary 26, 2023 | finanznachrichten.deNovozymes A/S: Novozymes delivers historically strong full-year resultsJanuary 26, 2023 | finance.yahoo.comNovozymes delivers historically strong full-year resultsJanuary 25, 2023 | msn.comEarnings Preview For NovozymesJanuary 24, 2023 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Given Average Rating of "Hold" by BrokeragesShares of Novozymes A/S (OTCMKTS:NVZMY - Get Rating) have been given a consensus rating of "Hold" by the ten research firms that are currently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, six have assigned a holdJanuary 23, 2023 | seekingalpha.comNovozymes: Wonderful Company, Almost Reasonable PriceDecember 30, 2022 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Given Consensus Rating of "Hold" by BrokeragesNovozymes A/S (OTCMKTS:NVZMY - Get Rating) has been given an average rating of "Hold" by the ten brokerages that are currently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and one hasDecember 29, 2022 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Short Interest Down 47.1% in DecemberNovozymes A/S (OTCMKTS:NVZMY - Get Rating) was the recipient of a large decrease in short interest during the month of December. As of December 15th, there was short interest totalling 900 shares, a decrease of 47.1% from the November 30th total of 1,700 shares. Based on an average trading volume of 41,500 shares, the days-to-cover ratio is currently 0.0 days.December 16, 2022 | marketbeat.comDeutsche Bank Aktiengesellschaft Lowers Novozymes A/S (OTCMKTS:NVZMY) to HoldDeutsche Bank Aktiengesellschaft downgraded shares of Novozymes A/S from a "buy" rating to a "hold" rating in a report on Friday.December 14, 2022 | marketbeat.comShort Interest in Novozymes A/S (OTCMKTS:NVZMY) Increases By 30.8%Novozymes A/S (OTCMKTS:NVZMY - Get Rating) was the recipient of a significant increase in short interest during the month of November. As of November 30th, there was short interest totalling 1,700 shares, an increase of 30.8% from the November 15th total of 1,300 shares. Based on an average daily volume of 30,000 shares, the days-to-cover ratio is currently 0.1 days.December 13, 2022 | msn.comBioscience firms Novozymes and Chr. Hansen to merge in biggest-ever Danish dealDecember 12, 2022 | bloomberg.comNovozymes Agrees to Buy Chr. Hansen in $12.3 Billion DealDecember 12, 2022 | finance.yahoo.comNovozymes shares slide after merger with rival Chr. Hansen unveiledDecember 12, 2022 | bizjournals.comLarge employer buys 50 acres in Franklin County next to its current siteDecember 12, 2022 | finanznachrichten.deNovozymes A/S: Novozymes and Chr. Hansen to combine and create a leading global biosolutions partnerDecember 12, 2022 | finance.yahoo.comNovozymes and Chr. Hansen agree deal to mergeDecember 12, 2022 | marketbeat.comJefferies Financial Group Weighs in on Novozymes A/S's FY2022 Earnings (OTCMKTS:NVZMY)Novozymes A/S (OTCMKTS:NVZMY - Get Rating) - Equities research analysts at Jefferies Financial Group dropped their FY2022 EPS estimates for shares of Novozymes A/S in a report issued on Thursday, December 8th. Jefferies Financial Group analyst C. Counihan now forecasts that the biotechnology compDecember 9, 2022 | marketbeat.comJefferies Financial Group Weighs in on Novozymes A/S's FY2023 Earnings (OTCMKTS:NVZMY)December 7, 2022 | marketbeat.comJPMorgan Chase & Co. Upgrades Novozymes A/S (OTCMKTS:NVZMY) to Overweight Get Novozymes A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVZMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Guard Against the Coming Financial Upheaval (Ad)America’s Most Shocking Financial Story… Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late. You can stream it for free right here. NVZMY Media Mentions By Week NVZMY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVZMY News Sentiment▼0.000.46▲Average Basic Materials News Sentiment NVZMY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVZMY Articles This Week▼00▲NVZMY Articles Average Week Get Novozymes A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVZMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Nutrien News Today Barrick Gold News Today Teck Resources News Today PPG Industries News Today Wheaton Precious Metals News Today DuPont de Nemours News Today Franco-Nevada News Today LyondellBasell Industries News Today Agnico Eagle Mines News Today Cameco News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:NVZMY) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaUrgent Nvidia WarningAltimetryNext President (Not Trump. Not Biden.)The Freeport SocietyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubMissed NVDA? Buy this AI stock NOWChaikin AnalyticsWhat’s Really Next for America…Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novozymes A/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
